Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)

About the company

Catalyst Pharmaceuticals is a biopharmaceutical company, which engages in the development and commercialization of therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases, including Lambert-Eaton myasthenic syndrome (LEMS), congenital myasthenic syndromes (CMS), MuSK antibody positive myasthenia gravis, spinal muscular atrophy (SMA) type 3, and infantile spasms. The company was founded by Huckel E. Hubert and Patrick J. McEnany in January 2002 and is headquartered in Coral Gables, FL.

Sector

Health Technology

Industry

Pharmaceuticals: Other

Employees

76

$119.00M

Total Revenue

76

Employees

$533.93M

Market Capitalization

12.17

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

$102M

Operating Margin (in %)

Total operating margin

$44M

Net Margin (in %)

Total net margin

$43M

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Horizon Therapeutics Plc HZNP 12018.30 1376.00 5.12 18.95 43.06
Catalent, Inc. CTLT 11623.49 2872.00 5.84 111.44 3.63
Perrigo Co. Plc PRGO 7607.61 4837.00 1.30 51.90 3.02
Jazz Pharmaceuticals Plc JAZZ 6076.20 2188.00 2.10 22.21 12.81
Bausch Health Cos., Inc. BHC 6068.07 8597.00 8.47 -3.21 -21.96
United Therapeutics Corp. UTHR 4985.85 1443.00 1.73 9.62 36.59
MyoKardia, Inc. MYOK 4168.52 34.00 12.11 -13.45 -201.73
Axsome Therapeutics, Inc. AXSM 2906.40 None 19.72 -32.31 None
Pacira Biosciences, Inc. PCRX 2427.60 435.00 6.51 -5780.00 -0.02
ArQule, Inc. ARQL 2240.00 5.00 15.75 -55.56 -808.06
SAGE Therapeutics, Inc. SAGE 2138.76 9.00 2.51 -3.30 -413.06
Corcept Therapeutics, Inc. CORT 2013.00 335.00 4.62 18.97 31.64
Prestige Consumer Healthcare, Inc. PBH 1863.54 963.00 1.57 13.14 14.77
Revolution Medicines, Inc. RVMD 1798.91 48.00 4.67 -25.41 -146.29
Madrigal Pharmaceuticals, Inc. MDGL 1558.65 0.00 4.16 -15.26 -624.74
Ironwood Pharmaceuticals, Inc. IRWD 1548.02 440.00 -21.91 18.26 19.14
Innoviva, Inc. INVA 1544.71 285.00 3.66 7.99 66.41
Intercept Pharmaceuticals, Inc. ICPT 1440.96 272.00 -42.89 -4.20 -127.53
Portola Pharmaceuticals, Inc. PTLA 1329.78 121.00 19.53 -4.77 -232.73
Supernus Pharmaceuticals, Inc. SUPN 1309.50 402.00 2.08 11.23 28.90
Theravance Biopharma, Inc. TBPH 1208.97 88.00 -8.48 -4.90 -280.80
Zogenix, Inc. ZGNX 1192.05 5.00 3.25 -2.80 -241.62
Revance Therapeutics, Inc. RVNC 1161.84 0.00 4.59 -6.23 41.82
Amphastar Pharmaceuticals, Inc. AMPH 996.66 327.00 2.49 19.56 15.90
Endo International Plc ENDP 775.20 3014.00 -1.06 -2.76 -9.09
BellRing Brands, Inc. BRBR 762.45 954.00 -0.41 5.78 13.98
Eagle Pharmaceuticals, Inc. EGRX 678.30 192.00 3.65 269.17 1.29
Assembly Biosciences, Inc. ASMB 667.58 16.00 2.99 -6.71 -601.75
Aerie Pharmaceuticals, Inc. AERI 638.73 79.00 5.07 -3.16 -252.92
Intersect ENT, Inc. XENT 577.76 102.00 5.45 -11.57 -48.61
Collegium Pharmaceutical, Inc. COLL 577.66 299.00 4.13 -44.71 -4.21
Catalyst Pharmaceuticals, Inc. CPRX 533.93 119.00 5.20 12.17 36.09
Anika Therapeutics, Inc. ANIK 494.90 125.00 1.71 17.85 22.73
BioDelivery Sciences International, Inc. BDSI 381.34 130.00 5.45 -51.81 -5.01
ANI Pharmaceuticals, Inc. ANIP 334.80 203.00 1.71 -214.62 -0.67
Albireo Pharma, Inc. ALBO 326.82 11.00 3.32 -4.28 -730.55
MEI Pharma, Inc. MEIP 275.56 5.00 4.74 -7.06 -539.48
Mallinckrodt Plc MNK 212.52 3037.00 0.11 -0.18 -39.56
Marinus Pharmaceuticals, Inc. MRNS 146.79 0.00 5.68 -2.18 None
Agile Therapeutics, Inc. AGRX 140.12 None 2.28 -6.79 None
Cerecor, Inc. CERC 118.22 7.00 7.56 -5.24 -429.22
Ampio Pharmaceuticals, Inc. AMPE 98.67 1.00 69.00 -5.31 None
Zynerba Pharmaceuticals, Inc. ZYNE 85.79 0.00 1.41 -2.39 -699.94
AcelRx Pharmaceuticals, Inc. ACRX 84.80 2.00 -1.56 -1.51 -644.25
Aclaris Therapeutics, Inc. ACRS 81.18 4.00 1.42 -0.59 None
Cassava Sciences, Inc. SAVA 76.66 41.00 4.03 -16.81 76.71
Adamas Pharmaceuticals, Inc. ADMS 75.32 57.00 -4.80 -0.81 -160.44
CTI BioPharma Corp. CTIC 71.98 3.00 3.21 -1.74 -111.83
Oramed Pharmaceuticals, Inc. ORMP 59.94 3.00 4.83 -4.69 -464.15
Cumberland Pharmaceuticals, Inc. CPIX 47.70 47.00 0.97 -10.60 -9.59
Natural Alternatives International, Inc. NAII 47.67 114.00 0.65 -12.61 -3.19
SCYNEXIS, Inc. SCYX 46.41 0.00 9.75 -1.20 -30.84
IsoRay, Inc. ISR 44.22 9.00 8.25 -13.20 -36.08
Lipocine, Inc. LPCN 40.20 0.00 9.57 -2.68 None
Acasti Pharma, Inc. ACST 35.84 827.00 2.33 -0.58 -7.45
Neos Therapeutics, Inc. NEOS 32.50 65.00 -2.50 -1.86 -26.74
PLx Pharma, Inc. PLXP 26.19 0.00 -2.51 -2.77 119.04
CytRx Corp. CYTR 22.11 0.00 1.60 -3.19 408.46
Evoke Pharma, Inc. EVOK 20.58 397.00 0.05 -7.15 -0.76
EyeGate Pharmaceuticals, Inc. EYEG 19.92 3.00 2.48 -1.68 -264.21
Regulus Therapeutics, Inc. RGLS 15.96 0.00 1.41 -0.75 -272.13
Tetraphase Pharmaceuticals, Inc. TTPH 12.15 8.00 0.64 -0.14 -798.18
Intec Pharma Ltd. NTEC 10.18 None 1.31 -0.24 None
Hepion Pharmaceuticals, Inc. HEPA 7.50 None 2.34 -0.63 None
Sonoma Pharmaceuticals, Inc. SNOA 6.44 19.00 1.02 -2.06 -25.58
KemPharm, Inc. KMPH 6.02 15.00 -0.17 -0.35 -120.48
VIVUS, Inc. VVUS 5.83 73.00 -0.13 -0.20 -39.28
Tonix Pharmaceuticals Holding Corp. TNXP 4.48 None 1.12 -0.09 None
Ritter Pharmaceuticals, Inc. RTTR 0.45 None 0.17 -0.03 None

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Hedge Funds Have Never Been This Bullish On Catalyst Pharmaceuticals, Inc. (CPRX)

21d ago, source: YAHOO!

In this article you are going to find out whether hedge funds think Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) is a good ...

Two Sigma Advisers LP Has $1.70 Million Position in Catalyst Pharmaceuticals Inc (NASDAQ:CPRX)

11d ago, source: theenterpriseleader.com

Two Sigma Advisers LP cut its position in Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) by 3.5% during the 1st quarter, ...

Catalyst Pharmaceuticals Appoints Jeffrey Del Carmen as Chief Commercial Officer

20d ago, source: MarketWatch

Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, ...

Catalyst Pharmaceuticals Inc.

22d ago, source: Barron's

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Soligenix, Inc.: Here’s Why The Remainder Of 2020 Is Expected To Be A Catalyst Filled Season

6d ago, source: MarketWatch

Jul 07, 2020 (AB Digital via COMTEX) -- Soligenix Inc. (NasdaqCM: SNGX) has been catching the attention of investors. Since May, shares are higher by ...

Laval Rocket season review: Laurent Dauphin was the catalyst for change

3d ago, source: Habs Eyes On The Prize on MSN.com

Laurent Dauphin joined the Laval Rocket in a trade that sent 2013 first-round pick Michael McCarron to the Milwaukee Admirals ...

2 Top Penny Stocks Get Up to 606% Profit Potential on Technology Catalysts

6d ago, source: Money Morning

The top penny stock today is getting a catalyst after some successful tests on a new drug it's developing. Watch it for 264% profit potential this ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.